Skip to main content

Advertisement

Log in

High level interleukin-6 in the medium of human pancreatic cancer cell culture suppresses production of neurotransmitters by PC12 cell line

  • Original Paper
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

It has been suggested that pancreatic cancer is associated with a greater prevalence of depression than many other cancers, but the mechanism accounting for this potential association has not yet been illustrated. In the present study, conditioned media (CM) from three pancreatic cancer cell lines and primary pancreatic cancer cells from two patients were added to culture system of differentiated pheochromocytoma cell line PC12. The release of dopamine (DA) and norepinephrine (NE) by PC12 was significantly inhibited after CM treatment (P < 0.05), similar to what happened after recombinant interleukin 6(IL-6) treatment. Furthermore, pretreatment with anti-IL-6 antibody significantly blocked the inhibitory effects of pancreatic cancer CM on DA and NE production (P < 0.05). We also demonstrated that tyrosine hydroxylase (TH), the rate-limiting enzyme for synthesis of catecholamine, was reduced after exposure to IL-6, which was accompanied by JAK-STAT3 pathway activation. Our results demonstrated that IL-6 in CM from pancreatic cancer down-regulated the production of DA and NE by PC12 cell. The possible underlying mechanisms might be decreasing TH production via activation of JAK-STAT3 signal transduction pathway. The present study might help to better understand the close relationship between pancreatic cancer and depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Appelberg BG, Syvalahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH (2001) Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. J Clin Psychiatry 62(6):448–452

    Article  PubMed  CAS  Google Scholar 

  • Bachtell RK, Tsivkovskaia NO, Ryabinin AE (2002) Alcohol-induced c-Fos expression in the Edinger-Westphal nucleus: pharmacological and signal transduction mechanisms. J Pharmacol Exp Ther 302(2):516–524

    Article  PubMed  CAS  Google Scholar 

  • Bartsch R, Woehrer S, Raderer M, Hejna M (2006) Serum interleukin-6 levels in patients with gastric MALT lymphoma compared to gastric and pancreatic cancer. Anticancer Res 26(4B):3187–3190

    PubMed  CAS  Google Scholar 

  • Bampton ET, Taylor JS (2005) Effects of Schwann cell secreted factors on PC12 cell neuritogenesis and survival. J Neurobiol 63(1):29–48

    Article  PubMed  CAS  Google Scholar 

  • Boyd AD, Riba M (2007) Depression and pancreatic cancer. J Natl Compr Canc Netw 5(1):113–116

    PubMed  Google Scholar 

  • Brown JH, Paraskevas F (1982) Cancer and depression: cancer presenting with depressive illness: an autoimmune disease? Br J Psychiatry 141:227–232

    Article  PubMed  CAS  Google Scholar 

  • Carney CP, Jones L, Woolson RF, Noyes R Jr, Doebbeling BN (2003) Relationship between depression and pancreatic cancer in the general population. Psychosom Med 65(5):884–888

    Article  PubMed  Google Scholar 

  • Cattaneo E, Conti L, De-Fraja C (1999) Signaling through the JAK-STAT pathway in the developing brain. Trends Neurosci 22(8):365–369

    Article  PubMed  CAS  Google Scholar 

  • Chourbaji S, Urani A, Inta I, Sanchis-Segura C, Brandwein C, Zink M et al (2006) IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol Dis 23(3):587–594

    Article  PubMed  CAS  Google Scholar 

  • Ciofu A, Baudin E, Chanson P, Cailleux AF, Comoy E, Sabourin JC et al (1999) Catecholamine production in patients with gastroenteropancreatic neuroendocrine tumors. Eur J Endocrinol 140(5):434–437

    Article  PubMed  CAS  Google Scholar 

  • Dantzer R (2004) Innate immunity at the forefront of psychoneuroimmunology. Brain Behav Immun 18(1):1–6

    Article  PubMed  CAS  Google Scholar 

  • Delgado PL, Moreno FA (2000) Role of norepinephrine in depression. J Clin Psychiatry 61(Suppl 1):5–12

    PubMed  CAS  Google Scholar 

  • Elwan O, Madkour O, Elwan F, Mostafa M, Abbas Helmy A, Abdel-Naseer M et al (2003) Brain aging in normal Egyptians: cognition, education, personality, genetic and immunological study. J Neurol Sci 211(1–2):15–22

    Article  PubMed  Google Scholar 

  • Frei K, Piani D, Pfister HW, Fontana A (1993) Immune-mediated injury in bacterial meningitis. Int Rev Exp Pathol 34 Pt B:183–192

    Google Scholar 

  • Gadient RA, Otten U (1994) Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 637(1–2):10–14

    Article  PubMed  CAS  Google Scholar 

  • Goodwill MH, Lawrence DA, Seegal RF (2007) Polychlorinated biphenyls induce proinflammatory cytokine release and dopaminergic dysfunction: protection in interleukin-6 knockout mice. J Neuroimmunol 183(1–2):125–132

    Article  PubMed  CAS  Google Scholar 

  • Grano M, Mori G, Minielli V, Cantatore FP, Colucci S, Zallone AZ (2000) Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts. Biochem Biophys Res Commun 270(3):1097–1100

    Article  PubMed  CAS  Google Scholar 

  • Gregersen R, Lambertsen K, Finsen B (2000) Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 20(1):53–65

    Article  PubMed  CAS  Google Scholar 

  • Gross PK, Nourse R, Wasser TE, Bukenya D (2007) Safety and efficacy of bupropion extended release in treating a community sample of Hispanic and african american adults with major depressive disorder: an open-label study. Prim Care Companion J Clin Psychiatry 9(2):108–112

    Article  PubMed  Google Scholar 

  • Hassan S, Kinoshita Y, Kawanami C, Kishi K, Matsushima Y, Ohashi A (1998) Expression of protooncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines. Dig Dis Sci 43(1):8–14

    Article  PubMed  CAS  Google Scholar 

  • Hernandez BY, Green MD, Cassel KD, Pobutsky AM, Vu V, Wilkens LR (2010) Preview of Hawaii cancer facts and figures 2010. Hawaii Med J 69(9):223–224

    PubMed  Google Scholar 

  • Holland JC, Korzun AH, Tross S, Silberfarb P, Perry M, Comis R et al (1986) Comparative psychological disturbance in patients with pancreatic and gastric cancer. Am J Psychiatry 143(8):982–986

    PubMed  CAS  Google Scholar 

  • Huang C, Yang G, Jiang T, Zhu G, Li H, Qiu Z (2011) The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro. Neoplasma 58(5):396–405

    Article  PubMed  CAS  Google Scholar 

  • Ireland LM, Yan CH, Nelson LM, Silberfarb P, Perry M, Comis R et al (1995) Differential effects of 2, 4-dithiobiuret on the synthesis and release of acetylcholine and dopamine from rat pheochromocytoma (PC12) cells. J Pharmacol Exp Ther 275(3):1453–1462

    PubMed  CAS  Google Scholar 

  • Jacobsson LO (1971) Initial mental disorders in carcinoma of pancreas and stomach. Acta Psychiatr Scand 220:120–127

    Article  Google Scholar 

  • Jandu N, Ceponis PJ, Kato S, Riff JD, McKay DM, Sherman PM (2006) Conditioned medium from entero hemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activator of transcription 1 activation by gamma interferon. Infect Immun 74(3):1809–1818

    Article  PubMed  CAS  Google Scholar 

  • Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG et al (2009) Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 9:155

    Article  PubMed  Google Scholar 

  • Knupfer H, Preiss R (2010) Serum interleukin-6 levels in colorectal cancer patients—a summary of published results. Int J Colorectal Dis 25(2):135–140

    Article  PubMed  Google Scholar 

  • Konsman JP, Parnet P, Dantzer R (2002) Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25(3):154–159

    Article  PubMed  CAS  Google Scholar 

  • Liang YQ, Tang XC (2006) Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats. Acta Pharmacol Sin 27(9):1127–1136

    Article  PubMed  CAS  Google Scholar 

  • Jia L, Jiang SM, Shang YY, Huang YX, Li YJ, Xie DR, et al (2009) Investigation of the incidence of pancreatic cancer-related depressin and ist relationship with the quality of life of patients. Digestion. In press

  • Joffe RT, Rubinow DR, Denicoff KD, Maher M, Sindelar WF (1986) Depression and carcinoma of the pancreas. Gen Hosp Psychiatry 8(4):241–245

    Article  PubMed  CAS  Google Scholar 

  • Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L et al (2009) Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 66(3):287–292

    Article  PubMed  CAS  Google Scholar 

  • Liu HQ, Zhu XZ, Weng EQ (2005) Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells. Acta Pharmacol Sin 26(1):17–26

    Article  PubMed  CAS  Google Scholar 

  • Makrilia N, Indeck B, Syrigos K, Saif MW (2009) Depression and pancreatic cancer: a poorly understood link. JOP 10(1):69–76

    PubMed  Google Scholar 

  • Malave C, Villegas GM, Hernandez M, Martínez JC, Castillo C, Suárez de Mata Z et al (2003) Role of glypican-1 in the trophic activity on PC12 cells induced by cultured sciatic nerve conditioned medium: identification of a glypican-1-neuregulin complex. Brain Res 983(1–2):74–83

    Article  PubMed  CAS  Google Scholar 

  • Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G et al (2009) The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 24(1):27–53

    Article  PubMed  CAS  Google Scholar 

  • Mayr M, Schmid RM (2010) Pancreatic cancer and depression: myth and truth. BMC Cancer 20(10):569

    Article  Google Scholar 

  • Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S et al (2001) Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 158(8):1252–1257

    Article  PubMed  CAS  Google Scholar 

  • Quan N, Herkenham M (2002) Connecting cytokines and brain: a review of current issues. Histol Histopathol 17(1):273–288

    PubMed  CAS  Google Scholar 

  • Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK (2007) The treatment of depression in cancer patients: a systematic review. Support Care Cancer 15(2):123–136

    Article  PubMed  Google Scholar 

  • Rivier C (1995) Influence of immune signals on the hypothalamic-pituitary axis of the rodent. Front Neuroendocrinol 16(2):151–182

    Article  PubMed  CAS  Google Scholar 

  • Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35(4):298–306

    Article  PubMed  CAS  Google Scholar 

  • Suwa T, Hogg JC, Vincent R, Mukae H, Fujii T, van Eeden SF (2002) Ambient air particulates stimulate alveolar macrophages of smokers to promote differentiation of myeloid precursor cells. Exp Lung Res 28(1):1–18

    Article  PubMed  Google Scholar 

  • Turaga KK, Malafa MP, Jacobsen PB, Schell MJ, Sarr MG (2010) Suicide in patients with pancreatic cancer. Cancer 117(3):642–647

    Article  PubMed  Google Scholar 

  • Watts ME, Parkins CS, Chaplin DJ (2002) Influence of hypoxia and tumour-conditioned medium on endothelial cell adhesion molecule expression in vitro. Anticancer Res 22(2A):953–958

    PubMed  CAS  Google Scholar 

  • Yarlagadda A, Alfson E, Clayton AH (2009) The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont) 6(11):18–22

    Google Scholar 

  • Zabora J, Brintzenhofe Szoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C et al (2001) A new psychosocial screening instrument for use with cancer patients. Psychosomatics 42(3):241–246

    Article  PubMed  CAS  Google Scholar 

  • Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H et al (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and −6. Brain Res 643(1–2):40–49

    Article  PubMed  CAS  Google Scholar 

  • Zhou H, Li X, Gao M (2009) Curcumin protects PC12 cells from corticosterone-induced cytotoxicity: possible involvement of the ERK1/2 pathway. Basic Clin Pharmacol Toxicol 104(3):236–240

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the PHD finance conduct.

Conflict of interest

All authors report no biomedical financial interests or potential conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jian Hou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, R., Hou, J., Xu, Q. et al. High level interleukin-6 in the medium of human pancreatic cancer cell culture suppresses production of neurotransmitters by PC12 cell line. Metab Brain Dis 27, 91–100 (2012). https://doi.org/10.1007/s11011-011-9270-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-011-9270-x

Keywords

Navigation